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ABSTRACT
Skimmed milk, caseins and whey proteins isolated from colostrums collected on the first to fifth days postpartum were hydrolyzed
by different enzymes (alcalase, flavourzyme, and porcine small-intestinal enzymes). To investigate how different protein hydrolyastes
affect cell death, leukemic U937 cells were treated with different protein hydrolysates at 100 - 1000 μg/mL for 24 to 120 h at 37°C in 5%
CO2 incubator. The results showed that protein hydrolysates leading to U937 cell death exhibited dose-and-time-dependent characteristics. This study also found that the proteins hydrolyzed by porcine small-intestinal enzymes have more significant effects on cell death
than proteins hydrolyzed by other enzymes. In addition, the colostrum protein hydrolysates from skimmed milk were better than those
from caseins and whey in inhibiting U937 cell growth.
Key words: colostrums, porcine small-intestinal enzymes, skimmed milk, protein hydrolysates, U937 cell

INTRODUCTION
Colostrums provide all the necessary nutrients, growth
factors and immunological components a healthy term infant
needs(1). Bovine colostrums are the first milk produced postpartum, and are typically defined as the first six postpartum
milkings collected during the period of transition from
colostrums to milk(2). Several researchers have compared
the compositions of colostrums with those of mature milk
and concluded that colostrums have higher protein, lower
fat, and a lactose solution rich in immunoglobulins and other
important immune factors and mediators(1,3-5). The major
differences between bovine colostrums and mature milk
are that colostrums have higher levels of immunoglobulins,
vitamins A and D, iron, calcium, as well as other vitamins
and minerals(6). Migliore-Samour et al.(7) and Meisel(8)
reported that the peptides derived from colostrum casein had
immunological enhancing activity. Some peptides, such as
Thr-Thr-Met-Pro-Leu-Trp, Pro-Gly-Pro-Ile-Pro-Asn, and
Leu-Leu-Try, can help reduce the infection rate of Klebsiella
pneumoniae in mice. Lindmark-Mansson and Akesson(9),
Satue-Gracia et al.(10) and Al-Mashikhi and Nakai(11)
reported that the lactoferrin derived from colostrums had
a high antioxidant activity, could scavenge free radicals
* Author for correspondence. Tel: +886-4-8511888 ext. 2283;
Fax: +886-4-8511322; E-mail: feccy@mail.dyu.edu.tw

generated in the human body, and also had a direct and positive effect on inhibiting atherosclerosis and ageing.
Food protein hydrolysates have been widely accepted
and applied in the field of cosmetics and healthcare products. Protein hydrolysate is a mixture of proteoses, peptones,
peptides, and free amino acids. It is possible, depending largely
on enzyme specificity and the degree of hydrolysis achieved,
to generate hydrolysate products with either enhanced or
reduced functionality. Significant interest exists in the hydrolytic release of bioactive peptide sequences encrypted within
the primary structure of food proteins(12). Several studies
have confirmed that protein hydrolysates should be rich in
low-molecular-weight peptides, such as di- or tri-peptides,
with as little free amino acids as possible, to qualify as
possessing high nutritional and therapeutic values(13,14).
Cell death is an essential process, being important
not only for normal development but also for the adult life
of many living organisms(15,16). A vast amount of literature
has reported on bovine colostrums and protein hydrolysates
for nutrition and functional food. The literature, however, is
limited in regard to bovine colostrums and protein hydrolysates for treating leukemia. Gill and Cross(17) reported on the
relationship between the assimilated quantity of colostrums
and anti-tumor results. Ma et al.(18) found, through an indirect
model, that bovine colostrums were capable of enhancing the
immunity for inducing human leukemic U937 cell death.
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The purpose of this study is to investigate the inhibitory
effects of different bovine colostrum protein hydrolysates on
human leukemic U937 cell growth through a direct model.

MATERIALS AND METHODS
I. Reagent
Roswell Park Memorial Institute (RPMI) 1640 medium
and fetal bovine serum (FBS) were purchased from Hyclone
(Logan, Utah, USA). Sodium bicarbonate, HEPES, L-glutamine, sodium pyruvate, alcalase (exo-peptidase; 2.4 Anson
unit (AU)/g), flavourzyme (exo/endo-peptidase; 0.5 unit/mg)
and N-benzoyl-L-arginine ethyl ester (BAEE) were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Trypan blue was purchased from e-Bioscience (CA, USA).
II. Preparation of Skimmmed Colostrums, Caseins and
Whey Proteins
The bovine colostrums used for this experiment were
acquired from a cow within five days after parturition
at the Chu-En Ranch, Hsiushui, Changhua, Taiwan. The
colostrums were collected at about 8 a.m. and promptly
centrifuged at 10,000 ×g for 30 min at 4°C to remove the fat.
After centrifugation the colostrums were adjusted to pH 4.6
with 1.0 N HCl and kept in a water bath at 30°C for 30 min
for the complete precipitation of caseins. The supernatant
thus obtained was adjusted to pH 7.0 with 1.0 N NaOH and
centrifuged again at 10,000 ×g for 30 min at 4°C. The final
supernatant after two centrifugations was treated as whey
proteins. Both the caseins and whey proteins were freezedried and stored in a desiccator at -80°C until used.
III. Preparation of Porcine Small-Intestinal Enzymes
The porcine small-intestines used for this experiment
were obtained from the Chin-Ku packinghouse in Beitoe,
Changhua, Taiwan. The extraction method was modified
from Simpson and Haard(19). Three hundred grams of the
porcine small-intestines were homogenized with 100 mL of
0.5 M Tris-HCl buffer (pH 7.5, containing 0.5 M of NaCl
and 0.2 M of CaCl2‧2H2O) for 1 min. The homogenate was
incubated for 4 h at 4°C, centrifuged and defatted twice
(12,000 ×g, 30 min, 4°C). The supernatant was collected
and treated as a crude enzyme preparation. A portion of the
enzyme sample was taken for an activity test; the remainder
was freeze-dried and powdered for protein hydrolysis and
stability tests, as well as electrophoresis analysis.
IV. Assay for Porcine Small-Intestinal Enzyme Activity with
BAEE
The activity test for the crude enzyme preparations was
implemented with the method developed by Hummel(20). The
rate of hydrolysis of N-benzoyl-arginine ethyl ester (BAEE)

was determined by the change in absorbance at 253 nm, under
a pH of 8.0, a temperature of 25°C and a 1.0 mM concentration of substrate. The BAEE unit is defined as the amount of
enzyme that will cause a change in absorbance of 0.001/min
under testing conditions. The BAEE unit converting method
is calculated by the following formula:
(A1 – A0) / min × (1 BAEE unit / 0.001 × min-1)
A1: absorbance of sample
A0: absorbance of control
V. Enzymatic Hydrolysis
The hydrolysis methods developed by Morato et al.(21),
Pintado et al.(22) and Spellman et al.(23) were summarized
and adopted. Two grams of protein samples were dissolved
in 100 mL of 0.01 N sodium phosphate buffer (pH 7.0) at
room temperature. The mixture, with a pH of around 4.6 to
7.0, was placed in a water bath maintained at 90°C for 30 min
to enable protein denaturation. The reaction pH levels were
adjusted to 8.0 for hydrolysis of porcine small-intestinal
enzyme perparations (enzyme/substrate (E/S) = 5%), pH 8.5
for alcalase hydrolysis (E/S = 3%) and pH 7.5 for flavourzyme
hydrolysis (E/S = 1.5%) with 2 N NaOH or HCl. These three
enzymes were added to the mixture at temperatures of 37,
50 and 40°C, respectively. The reactions were terminated by
immersing the beaker into a water bath at 85°C for 5 min(24).
The degree of hydrolysis (DH) of colostrum protein hydrolysate was calculated as (amino nitrogen/total nitrogen) ×
100%, where the total nitrogen and amino nitrogen content
were determined by the semimicro-Kjeldahl method(25) and
the formol titration method(26), respectively.
VI. Preparation of Sample Solution
Bovine colostrums, caseins, whey proteins and their
hydrolysate samples were dissolved in a phosphate buffer
solution (8 g NaCl, 1.15 g Na2HPO4, 0.2 g KH2PO4, 0.2 g KCl
dissolved 1 L dd. H2O, pH 7.0). The sample concentrations
were prepared at 100, 200, 400, 500, 800 and 1000 μg/mL.
Concurrently, penicillin and streptomycin (20 μL/mL) were
added to each sample, all of which were filtered by a 0.22-μm
filter for the cell experiment. The abbreviations, PIS, ALS,
FLS, PIC, ALC, FLC, PIW, ALW and FLW, denote the
hydrolysates of skimmed colostrums (S), caseins (C), and
whey (W) obtained by porcine small-intestinal enzymes
(PI), alcalase (AL), and flavourzyme (FL), respectively.
VII. Protein Analysis by SDS-PAGE
The sample (0.03 g) was dissolved in 2 mL of 0.5 M
Tris-HCl buffer (pH 7.5). Ten μL of the protein-sample liquid
was added with 10 μL lysis buffer containing 0.5 M Tris
(pH 6.8), 2% bromophenol blue, 10% SDS, 75% glycerol,
5% β-mercaptoethanol and distilled water. The sample was
then loaded on a 15.0% acrylamide gel (gel concentration:
stacking gel, 4.5%; resolving gel, 15.0%) for electrophoresis.
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An electrophoresis apparatus Model AE-6450 (ATTO,
Japan) and a power supplier PS500XT with a 2.5 AMP
input (Hoefer scientific instruments, USA) were used. The
electrophoresis was started at 70 V and subsequently turned
up to 140 V after a tracer dye was added to the resolving gel.
This voltage was maintained until the dye reached the bottom
of the gel. The gels were then immersed in coomassie blue
for 2 h and the color was stripped by a solution containing
7% methanol and 7% acetic acid.
VIII. Cell Cultures
U937 cell lines were obtained from the Bioresource
Collection and Research Center (BCRC). The cells were
cultured in RPMI 1640, supplemented with 10% heat inactivated fetal bovine serum, penicillin (100 units/mL), streptomycin (100 μg/mL), HEPES (100 μg/mL), sodium pyruvate
and sodium bicarbonate, and subsequently incubated at 37°C
in a humidified atmosphere containing 5% CO2.
IX. Bovine Colostrums Affecting Cell Death as Determined
by Trypan Blue
U937 cells at 1 × 105 cells/mL treated with different
protein hydrolysates at 100, 200, 500, 800 and 1000 μg/mL
were placed into a 12-well microtiter plate for 24, 72 and
120 h, respectively, at 37°C in 5% CO2 (cell/samples ratio =
4/1, v/v). The control was treated with both the medium and a
PBS. The number of dead cells was counted in a trypan blue
dye exclusion test(27).
Growth inhibition (%) = (1-(Number of live cells / total
cells)) × 100%
X. The Growth of Human Mononuclear Cells (MNC) as
Determined by MTT Assay
Human peripherical blood was obtained from healthy
adult volunteers between the ages of 22 and 25. MNCs were
recovered by adding the blood to Ficoll-Hypaque solution (1.077 g/mL) (from Sigma Chemical Co., USA) and
centrifuging at 400 ×g for 30 min. A suspension of 1.0 ×
107 cells/mL in an RPMI 1640 medium was prepared.
Human MNCs were incubated with colostrum proteins
and their hydrolysates, mediums, PBS (control) and PHA
(phytohemagglutinin, positive control, 5 μg/mL) at 37°C in
5% CO2 for 1 and 3 days (cell/samples ratio = 4/1, v/v). Then,
25 μL of MTT reagent was added and the cells were incubated for another 4 h at 37°C in 5% CO2. One hundred μL of
MTT lysis buffer (25 mL N,N-dimethyl formamide (DMF)
and sodium dodecyl sulfate 10 g/ mL were mixed) was then
added and the cells incubated for 16 - 18 h at 37°C in 5%
CO2. The absorbance was measured at 570nm. The growth
index was calculated by applying the following equation:
Growth index = (MTT value of sample stimulated cells
/ MTT value of medium control cells)

XI. Statistical Analysis
In this study, each experiment was conducted in triplicate and the results analyzed by one-way analysis of variance
in SAS (Statistic Analytic System) (SAS, 2001).

RESULTS AND DISCUSSION
I. Activity and Stability of Porcine Small-Intestinal
Enzymes
In this study the activity of a crude enzyme preparation
from porcine small-intestine was first assayed. Trypsin, the
major enzyme in the intestine, was chosen as the enzymatic
activity indicator. Since the enzyme preparation was not
purified beforehand, various proteins were present in the
mixture. The BAEE unit converting method was employed
to calculate the activity of the porcine small-intestinal
enzymes, measured at 516.60 BAEE units/mg solid. After
the freeze-dried crude enzyme preparations were stored
at -20°C for 14 days the activity decreased by 9.88%. On
the 21st day, the activity had decreased by 17.63% (data not
shown). Hence, to ensure the enzymatic activity remained
at high level during protein hydrolysis, the porcine smallintestinal enzyme preparation used in the experiment was
stored for not longer than 14 days after preparation.
II. Electrophoresis Analysis
Figure 1 depicts the electrophoresis analysis of the
protein samples and crude enzyme preparation extracted
from porcine small-intestines. Figure 1 (A) indicates that
the enzyme preparation contains several proteins because
this preparation is crude. After comparing the results with
the trypsin electrophoresis results obtained by Kurtovic et
al.(28), Francis et al.(29), and Keryn et al.(30), it is evident that
the band of 25 - 35 kDa in the electropherogram is trypsin.
Moreover, after comparing the electrophoresis reports
by Burn and Dalgleish(31) and Hekmat and McMahon(32)
regarding bovine colostrums proteins, it is also evident that
the bands of 75 - 100, 30 - 35, 25 - 30, 23 - 25, 20 - 23, 15 - 20,
and 10 - 15 kDa in Figure 1 (B), (C), and (D) are lactoferrin,
αs2-casein, αs1-casein, β-casein, κ-casein, β-lactoglobuin, and
α-lactalbumin, respectively. An examination of Figure 1 (E)
reveals that lanes 2, 3, and 4 have more low-molecular weight
bands than lane 1 and exhibit different distributions of these
bands. These results indicate that different enzymes exhibit
different capabilities in terms of hydrolysis.
III. Hydrolysis of Bovine Colostrum Proteins
Most protein hydrolysates are obtained by using
commercial enzymes from microorganisms. Commercial
enzymes are often in pure form and have high activity.
Although only small amounts are usually needed for effective results, these enzymes are, nevertheless, expensive.
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Figure 1. SDS-PAGE Patterns. (A) crude enzymes extracted from porcine small intestine, Lane S: standard, Lane 1: trypsin from SIGMA
Chemical Co., USA, Lane 2: crude enzyme from porcine small-intestine; (B) skimmed colostrums, (C) caseins, and (D ) whey, Lane S: standard, Lane 1-5: day 1-5 colostrum proteins, respectively; (E) hydrolysates of skimmed colostrums, Lane 1: skimmed colostrums, Lane 2: hydrolysates by alcalase, Lane 3: hydrolysates of flavourzyme, and Lane 4: hydrolysates of porcine small-intestinal enzymes.

Porcine small-intestinal enzyme preparation is inexpensive and can be produced in large amounts. Figure 2 plots
the changes in the degree of hydrolysis (DH) of skimmed
colostrums hydrolyzed by different enzymes, indicating that
the DHs of the hydrolysates increased with hydrolysis time,
results similar to those obtained by Chiang and Chang(33).
The DHs measured on day 2 sample were the lowest among
the five days of samples, thereby revealing that the structure
and the compositions of the proteins of day 2 colostrums
significantly differ from those observed on the other days.
IV. Effect of Bovine Colostrums on U937 Cell Growth
There are two ways to evaluate the effects of natural
substances on the growth of leukemic cells, either by direct
inhibition on the proliferation of the cells or by stimulating the
secretion of differentiation-inducing factors from immune
cells to act indirectly on the leukemic cells. In this study the
effects of different protein hydrolysates on the growth of
U937 cells were studied via a direct model.

The results in Table 1 show that the days on which the
colostrums were collected are significantly related to cell
growth. As the number of collection days increased, the
inhibition of U937 cell growth decreased, and the inhibition rates of the colostrum hydrolysates were higher than
those of the colostrums. When the cells were exposed for
120 hrs to the hydrolysates obtained from porcine smallintestinal enzymes (PIS) of colostrums collected on the 1st
- 5th days, the inhibition rates of cell growth were 56.20,
55.27, 52.71, 43.93, and 35.65, respecively. The low inhibition rate of the day 5 colostrum hydrolysates accounts for
bovine colostrums collected on the fifth day postpartum
being almost the same as for mature milk. Kelly(6) observed
that the difference between bovine colostrums and mature
milk is that there are higher levels of immunoglobulins,
proteins, vitamins A and D, iron, calcium, as well as other
vitamins and minerals, in colostrums than in mature milk.
The change in the inhibition rates of U937 cell growth can be
attributed to the respective protein compositions. Meisel(8)
reported that milk proteins were precursors of many

313
Journal of Food and Drug Analysis, Vol. 19, No. 3, 2011

(A) Alcalase

60

25

50

20

40

DH %

DH %

30

15

30

10

20

5

10

0

0 1

4

8

12

18

0

24

(B) Flavourzyme

0 1

4

8

Time (h)
30

12

18

24

Time (h)

(C) Porcine small-intestinal enzymes

25

DH %

20
15
10
5

Figure 2. Change in the degree of hydrolysis (DH) of skimmed
colostrums collected on 1st to 5th days postpartum and hydrolyzed by
different enzymes. (A) Alcalase, (B) Flavourzyme and (C) Porcine
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Table 1. Growth inhibition of U937 cells treated with skimmed colostrum hydrolysates (1000 μg/mL) collected on different days postpartum
Growth inhibition (%)
Sample

Day 1

Day 2

Day 3

17.24 ± 1.18

18.92 ± 0.90b

56.20 ± 0.51a

55.27 ± 1.75a

52.71 ± 0.77a

43.93 ± 0.89a

35.65 ± 0.61a

a

a

a

a

42.01 ± 0.90

34.10 ± 0.41a

42.71 ± 0.38a

37.87 ± 1.50a

PIS
ALS

52.54 ± 1.20

53.15 ± 1.52

FLS

55.37 ± 1.23a

55.92 ± 1.04a

b

Day 5

20.40 ± 0.96

25.88 ± 1.25

b

Day 4

27.23 ± 0.46

Skimmed colostrums

b

51.56 ± 0.52

51.6 ± 0.58a

PBS

3.96 ± 0.45

Medium

4.30 ± 0.28

b

Means with identical letters in same column are not significantly different (p > 0.05).

different biologically active peptides. The peptides are inactive within the sequence of the precursor proteins but active
while being released by enzymatic proteolysis. Although the
day 2 colostrums have the lowest degree of hydrolysis, the
highest inhibition rates of their hydrolysates on the U937
cell growth reveal that the function of the peptides released
by enzymatic hydrolysis is not directly related to the degree
of hydrolysis, but significantly dependent on the hydrolysis

site and peptide sequence.
After obtaining the aforementioned results, we then
used the hydrolysates of the day 2 colostrums as samples to
investigate their effects on the growth of U937 cells.
To determine the effects of different colostrum protein
hydrolysates on the inhibition of U937 cell growth, the U937
cells were all exposed to PIS, ALS and FLS at a concentration of 1000 μg/mL for 24, 72 and 120 h. The graphs
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Figure 3. Growth inhibition of U937 cells treated with hydrolysates of day 2 skimmed colostrums at concentration of 100, 200, 500, 800 and
1000 μg/mL.

in Figure 3 indicate that the growth of cells was slightly
inhibited under treatments for 24 and 72 h. The inhibition
rates were 17.76 - 28.76% for PIS, 18.13 - 25.05% for ALS
and 18.58 - 24.02% for FLS. However, when the U937 cells
were treated for 120 h, all the hydrolyslate samples inhibited U937 cell growth by more than 50% (the inhibition rate
being 55.27% for PIS, 53.15% for ALS and 55.92% for FLS).
Skimmed colostrums inhibited the growth of U937 cells by
only 13.57 - 27.24% during the testing period. When the cells
were exposed to various concentrations of the samples for
various periods, the cell growth was significantly inhibited
in a dose-and-time-dependent manner. Similarly, the growth
inhibition of U937 cells treated with berberine at 75 μg/mL
for 24 h was 80%(34); U937 cells treated with Chlorpyrifos at
285 μM for 2, 4 and 6 h were 57, 78 and 80%, respectively(35);
these inhibition rates were higher than those in our experiments. The growth inhibition of human lung carcinoma A549
epithelial cells treated with Tremella mesenterica extract at
1000 μg/mL for 24, 48 and 120 h were 25 - 31.7%(36), which

were lower than those in our experiments.
Table 2 lists the growth inhibition data for U937 cells
treated with different protein hydrolysates (1000 μg/mL) of
colostrums collected on the second day postpartum. When
the cells were exposed to these samples at a concentration
of 1000 μg/mL for 120 h, it was found that the growth was
significantly inhibited. The cell growth inhibition rates were
55.27% for PIS, 53.17% for ALS, 55.92% for FLS; 45.13%
for PIC, 41.56% for ALC, 43.12% for FLC; and 40.08% for
PIW, 37.12% for ALW, 40.11% for FLW. An examination of
the results presented in Table 2 reveals that the inhibition rate
of the cells treated with skimmed colostrum hydrolysates is
higher than those treated with the caseins and the whey hydrolysates. The manner in which the peptide sequences of the
casein hydrolysates obtained by trypsin affect the inhibition
of cell growth has been studied by several researchers(37-41).
In this study, the samples hydrolyzed by porcine small-intestinal enzymes had a more profound effect on cell growth than
the samples hydrolyzed by other enzymes.
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Table 2. Growth inhibition of U937 cells treated with different protein hydrolysates (1000 μg/mL) of colostrums collected on the second day
postpartum
Growth inhibition (%)
Sample
PIS

Sample
55.27 ± 1.75

aA

Sample

ALS

aA

FLS

55.92 ± 1.04aA

bC

53.17 ± 0.37

PIC

bA

45.13 ± 0.37

ALC

41.56 ± 0.71

FLC

43.12 ± 0.51bB

PIW

40.08 ± 0.41cA

ALW

37.12 ± 0.33cB

FLW

40.11 ± 0.62cA

PBS

3.96 ± 0.45

Medium
4.30 ± 0.28
A-C Means with identical letters in the same row are not significantly different (p > 0.05); a-c Means with identical letters in the same
column are not significantly different (p > 0.05).

V. Bovine Colostrum Proteins and Their Hydrolysates
Affecting the Growth of MNC
Table 3 illustrates the effect of Bovine colostrum
proteins and their hydrolysates on MNC growth. The MNC
treated with bovine colostrum proteins and their hydrolysates had more effect on the growth of MNC than did the
PBS-treated control group. The greatest growth index, up
to 1.43, was achieved by a treatment of PIS at 300 μg/mL
for 3 days. MNC treated with the positive control (PHA;
5 μg/mL) growth index was 1.54. From the results, one may
deduce that the bovine colostrum protein and its hydrolysates
are able to stimulate MNC growth.

CONCLUSIONS
In this study, it was observed that the proteins hydrolyzed by porcine small-intestinal enzymes had the greatest
ability to inhibit cell growth; moreover, the skimmed colostrum hydrolysates had higher inhibition rates than caseins
and whey hydrolysates. The most likely explanation is that the
hydrolysate samples had different peptide compositions and
different amino acid sequences, due to the different enzymes
used for hydrolysis. Several articles(37-42) have reported that
milk protein hydrolysates are directly related to cellular reactions. Goldsby et al.(43) proposed a possible mechanism as
that the small peptide molecules could penetrate the cancer
cell wall, inhibit protein synthesis, thereby affect the cell
RNA and DNA synthesis, and ultimately change cell shape
as well as function to make it quick death. Another possible
mechanism is that the cell membrane receptor is combined
with the peptides, resulting in that the cells can not get sufficient nutrients, ultimately leading to death.
This research also demonstrated that the days on which
the colostrums were collected were significantly correlated
with cell growth (Table 1). Gauthier et al.(42) reported that
bovine colostrums contain a number of growth factors,
hormones and cytokines; however, the distinction between
these molecules is not clear, since they all can be involved
in cell proliferation and differentiation. It may be stated
from the above results that bovine colostrum proteins and

Table 3. The growth index of human mononuclear cells incubated
with colostrum proteins and their hydrolysates for 24 and 72 h
Human mononuclear cells growth index
Sample

incubation time

(300 µg/ mL)

24 h

72 h
abA

1.20 ± 0.09 aA

Casein

abA

1.13 ± 0.08

1.17 ± 0.06aA

Whey

1.04 ± 0.05bcA

1.08 ± 0.08aA

PIS

1.27 ± 0.04aB

1.43 ± 0.20aA

PIC

aB

1.26 ± 0.04

1.37 ± 0.05aA

PIW

1.11 ± 0.03abB

1.27 ± 0.01aA

ALS

abB

1.16 ± 0.04

1.36 ± 0.06aA

ALC

1.17 ± 0.04abB

1.26 ± 0.07aA

ALW

1.13 ± 0.03

abB

1.26 ± 0.02 aA

FLS

1.29 ± 0.08aA

Skimmed colostrums

1.18 ± 0.09

1.33 ± 0.15aA

FLC

abA

1.19 ± 0.07

1.21 ± 0.03aA

FLW

1.12 ± 0.04abB

1.21 ± 0.02 aA

PBS

1.07 ± 0.35

1.09 ± 0.43

PHA(5 μg/mL)

1.43 ± 0.05

1.54 ± 0.59

A-B: Data with identical letter in the same row are not significantly
different (p > 0.05). a-c: Data with identical letter in the same
column are not significantly different (p > 0.05).

their hydrolysates not only inhibit the growth of U937 cells
but also stimulate the growth of MNC. The bioactivities of
protein hydrolysates are most likely related to peptides and/
or free amino acids liberated during digestion. However, the
possibility of the unknown compounds should also be kept
in mind.
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